Kohichiro Yoshino
President presso CARNA BIOSCIENCES, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Provenienza dei contatti di primo grado di Kohichiro Yoshino
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Unknown | 14 | ||
CarnaBio USA, Inc.
 CarnaBio USA, Inc. Medical DistributorsDistribution Services CarnaBio USA, Inc. provides biologicals and allied products. The company is headquartered in Natick, MA.
7
| Subsidiary | Medical Distributors | 7 |
| Public Company | Biotechnology | 5 | |
| Public Company | Biotechnology | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kohichiro Yoshino tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AIR WATER INC. | Chemicals: Specialty | Director/Board Member | |
| Keio University | College/University | Undergraduate Degree | |
| TOYO GOSEI CO.,LTD. | Chemicals: Specialty | Director/Board Member | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| ADVANCED MEDIA, INC. | Packaged Software | Director/Board Member | |
| NICHIRYOKU CO.,LTD. | Engineering & Construction | Chairman | |
| University of Tokyo | College/University | Undergraduate Degree | |
| NANO MRNA CO.,LTD. | Pharmaceuticals: Other | Director/Board Member | |
| AXEL MARK INC. | Advertising/Marketing Services | Director/Board Member | |
| ALBERT | Packaged Software | Director/Board Member | |
| Japan Health Sciences Foundation | Chairman | ||
Mitsui & Co. Global Strategic Studies Institute
 Mitsui & Co. Global Strategic Studies Institute Miscellaneous Commercial ServicesCommercial Services Mitsui & Co. Global Strategic Studies Institute operates as an in-house research institute of Mitsui & Co. Ltd. It provides surveys and research in the fields of politics, economics, industry, society, technology, and innovation. The company was founded in October 1999 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| CRI MIDDLEWARE CO., LTD. | Packaged Software | Director/Board Member | |
Whiz Partners, Inc.
 Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010. | Investment Managers | Chief Operating Officer | |
Glamo, Inc.
 Glamo, Inc. Computer CommunicationsElectronic Technology Glamo, Inc. engages in IoT platform, system license, and hardware original equipment manufacturer (OEM) businesses. Its products include iRemocon and Glamo Smart Lock. The company was founded by Isao Goto on February 2, 2011 and is headquartered in Tokyo, Japan. | Computer Communications | Director/Board Member | |
Aristagora Advisors Co., Ltd.
 Aristagora Advisors Co., Ltd. Investment ManagersFinance Aristagora Advisors Co., Ltd. (Aristagora Advisors) is an independent venture capital firm founded in 2007. The firm is headquartered in Tokyo, Japan. | Investment Managers | Director/Board Member | |
| Kyoto Prefectural Sagano High School | College/University | Undergraduate Degree | |
| T&R Holdings Co., Ltd. | Director/Board Member | ||
| Aristagora Financial Services Co., Ltd. | Chairman | ||
KinoPharma, Inc.
 KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
PharmaBio Corp.
 PharmaBio Corp. BiotechnologyHealth Technology PharmaBio Corp. provides manufacturing and consulting company specializing in cellular and tissue based products. It offers of cell-based investigational new drugs, various contract testing and inspections including microbial safety testing of cells, specimen storage operations, development, manufacturing and marketing of clean room consumables and various equipment. The company was founded in April 1978 and is headquartered in Nagoya, Japan. | Biotechnology | Director/Board Member | |
| Aristagora International Pte Ltd. | Director/Board Member | ||
| Aristagora Asset Management Pte Ltd. | Director/Board Member | ||
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Pharmaceuticals: Major | Director/Board Member | |
| GenAhead Bio, Inc. | Director/Board Member | ||
Aristagora VC Israel Technology LP
 Aristagora VC Israel Technology LP Investment ManagersFinance Aristagora VC Israel Technology LP invests in companies located in the Israel. The fund targets companies operating in the field of technology. It provides financing for seed stage and early stage capital requirements with an investment size of between $500k and $1.5 million per company. | Investment Managers | President | |
| Aristagora VC Israel Management Ltd. | Investment Managers | President | |
| Aristagora VC Israel GP Ltd. | Director/Board Member | ||
| MyMetagenome Co. Ltd. | Director/Board Member | ||
Hinge Therapeutics, Inc.
 Hinge Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Hinge Therapeutics, Inc. is an early-stage biopharmaceutical company based in Torrance, CA. The private company focuses on developing small-molecule therapeutics against traditionally undruggable/challenging targets for unmet medical needs. The company's proprietary technology, the Hinge drug discovery platform, has generated several novel inactivators against targets which are traditionally targeted only by large molecules such as antibody and siRNA. The current areas of interest include bleeding disorders, solid tumors, cardiovascular diseases, CNS, rare disease, and anti-aging. Hinge Therapeutics is seeking investors/partners who can help them advance their programs while further establishing their "Hinge drug discovery platform" which can be applied to many other challenging targets. The company was founded by Yoshihiko Futamura, and the CEO is Akiko Futamura. | Pharmaceuticals: Other | Chief Executive Officer | |
Institute of Accelerator Analysis, Ltd.
 Institute of Accelerator Analysis, Ltd. Miscellaneous Commercial ServicesCommercial Services Institute of Accelerator Analysis Ltd. provides accelerator mass spectrometry analysis services. Its specializes in pharmacokinetic analysis and radiocarbon dating. The firm also offers in-vitro studies in the early stages of drug development as well as drug concentration measurement in biological samples. The company was founded by Takao Mutsui on March 29, 1999 and is headquartered in Kawasaki, Japan. | Miscellaneous Commercial Services | Chief Executive Officer | |
| KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member | |
| STEMRIM | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Giappone | 29 |
| Stati Uniti | 4 |
| Singapore | 3 |
| Israele | 3 |
| Isole Cayman | 2 |
Settori
| Health Technology | 8 |
| Commercial Services | 6 |
| Finance | 5 |
| Consumer Services | 4 |
| Technology Services | 4 |
Posizioni
| Director/Board Member | 53 |
| Corporate Officer/Principal | 13 |
| President | 10 |
| Chairman | 5 |
| Chief Executive Officer | 5 |
Contatti più connessi
- Borsa valori
- Insiders
- Kohichiro Yoshino
- Connessioni Società
